4//SEC Filing
Exter Neil 4
Accession 0000899243-21-008467
CIK 0001628171other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 6:14 PM ET
Size
9.2 KB
Accession
0000899243-21-008467
Insider Transaction Report
Form 4
Exter Neil
Director
Transactions
- Other
Common Stock
2021-02-24−0→ 0 total(indirect: See footnote)
Holdings
- 0(indirect: See footnote)
Common Stock
- 19,998
Common Stock
- 19,998(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]On February 24, 2020, Third Rock Ventures III, L.P. ("TRV III") distributed for no consideration 1,500,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Third Rock Ventures GP III, L.P. ("TRV GP III"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended. After such distribution, TRV III directly held 5,524,031 shares of Common Stock of the Issuer.
- [F2]The Reporting Person is a partner of each of Third Rock Ventures GP II, L.P., TRV GP III and Third Rock Ventures GP IV, L.P. which is the general partner of each of Third Rock Ventures II, L.P. ("TRV II"), TRV III and Third Rock Ventures IV, L.P. ("TRV IV" and collectively with TRV II and TRV III, "the Funds"), respectively. The Reporting Person disclaims beneficial ownership over the shares held by the Funds, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
- [F3]TRV II directly holds 1,909,317 shares of Common Stock of the Issuer and TRV IV directly holds 1,419,900 shares of Common Stock of the Issuer.
- [F4]The shares are directly held by the Reporting Person. Includes Shares received in the distributions described in footnote (1) above.
- [F5]The shares are directly held in certain estate-planning trusts over which the Reporting Person may have voting and dispositive power. The Reporting Person disclaims beneficial ownership over the shares held by such trusts except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares. Includes Shares received in the distributions described in footnote (1) above.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001620014
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 6:14 PM ET
- Size
- 9.2 KB